These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31572976)

  • 1. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis.
    Chen PY; Qin L; Li G; Wang Z; Dahlman JE; Malagon-Lopez J; Gujja S; Cilfone NA; Kauffman KJ; Sun L; Sun H; Zhang X; Aryal B; Canfran-Duque A; Liu R; Kusters P; Sehgal A; Jiao Y; Anderson DG; Gulcher J; Fernandez-Hernando C; Lutgens E; Schwartz MA; Pober JS; Chittenden TW; Tellides G; Simons M
    Nat Metab; 2019 Sep; 1(9):912-926. PubMed ID: 31572976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies.
    Döring Y; Noels H; van der Vorst EPC; Neideck C; Egea V; Drechsler M; Mandl M; Pawig L; Jansen Y; Schröder K; Bidzhekov K; Megens RTA; Theelen W; Klinkhammer BM; Boor P; Schurgers L; van Gorp R; Ries C; Kusters PJH; van der Wal A; Hackeng TM; Gäbel G; Brandes RP; Soehnlein O; Lutgens E; Vestweber D; Teupser D; Holdt LM; Rader DJ; Saleheen D; Weber C
    Circulation; 2017 Jul; 136(4):388-403. PubMed ID: 28450349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLIC1 Inhibition Attenuates Vascular Inflammation, Oxidative Stress, and Endothelial Injury.
    Xu Y; Zhu J; Hu X; Wang C; Lu D; Gong C; Yang J; Zong L
    PLoS One; 2016; 11(11):e0166790. PubMed ID: 27861612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression.
    Chen PY; Qin L; Li G; Tellides G; Simons M
    EMBO Mol Med; 2016 Jul; 8(7):712-28. PubMed ID: 27189169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-to-mesenchymal transition drives atherosclerosis progression.
    Chen PY; Qin L; Baeyens N; Li G; Afolabi T; Budatha M; Tellides G; Schwartz MA; Simons M
    J Clin Invest; 2015 Oct; 125(12):4514-28. PubMed ID: 26517696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy.
    Beldman TJ; Malinova TS; Desclos E; Grootemaat AE; Misiak ALS; van der Velden S; van Roomen CPAA; Beckers L; van Veen HA; Krawczyk PM; Hoebe RA; Sluimer JC; Neele AE; de Winther MPJ; van der Wel NN; Lutgens E; Mulder WJM; Huveneers S; Kluza E
    ACS Nano; 2019 Dec; 13(12):13759-13774. PubMed ID: 31268670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polarity protein Scrib limits atherosclerosis development in mice.
    Schürmann C; Dienst FL; Pálfi K; Vasconez AE; Oo JA; Wang S; Buchmann GK; Offermanns S; van de Sluis B; Leisegang MS; Günther S; Humbert PO; Lee E; Zhu J; Weigert A; Mathoor P; Wittig I; Kruse C; Brandes RP
    Cardiovasc Res; 2019 Dec; 115(14):1963-1974. PubMed ID: 30949676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis.
    Volger OL; Fledderus JO; Kisters N; Fontijn RD; Moerland PD; Kuiper J; van Berkel TJ; Bijnens AP; Daemen MJ; Pannekoek H; Horrevoets AJ
    Am J Pathol; 2007 Jul; 171(1):326-37. PubMed ID: 17591977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.
    Mallat Z; Gojova A; Marchiol-Fournigault C; Esposito B; Kamaté C; Merval R; Fradelizi D; Tedgui A
    Circ Res; 2001 Nov; 89(10):930-4. PubMed ID: 11701621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
    Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
    Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus Receptor-Related 2: A Cholesterol-Responsive Gene Affecting Atherosclerosis Development by Modulating Leukocyte Migration.
    Rossignoli A; Shang MM; Gladh H; Moessinger C; Foroughi Asl H; Talukdar HA; Franzén O; Mueller S; Björkegren JL; Folestad E; Skogsberg J
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):534-542. PubMed ID: 28062492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.
    Gareus R; Kotsaki E; Xanthoulea S; van der Made I; Gijbels MJ; Kardakaris R; Polykratis A; Kollias G; de Winther MP; Pasparakis M
    Cell Metab; 2008 Nov; 8(5):372-83. PubMed ID: 19046569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression.
    Chen PY; Qin L; Barnes C; Charisse K; Yi T; Zhang X; Ali R; Medina PP; Yu J; Slack FJ; Anderson DG; Kotelianski V; Wang F; Tellides G; Simons M
    Cell Rep; 2012 Dec; 2(6):1684-96. PubMed ID: 23200853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study.
    Piao M; Tokunaga O
    J Atheroscler Thromb; 2006 Apr; 13(2):82-9. PubMed ID: 16733295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.